# SALIX PHARMACEUTICALS LTD: Form D filing

SALIX PHARMACEUTICALS LTD, a pharmaceuticals company in Raleigh, NC, filed a Form D with the SEC in 2014. The latest, on January 10, 2014, reports $750 million sold of a $750 million offering to 7 investors.

Find out what SALIX PHARMACEUTICALS LTD does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SALIX%20PHARMACEUTICALS%20LTD%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SALIX%20PHARMACEUTICALS%20LTD&page=%2Fdata%2Fform-d%2Fcompany%2Fsalix-pharmaceuticals-ltd-1009356)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SALIX%20PHARMACEUTICALS%20LTD%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SALIX%20PHARMACEUTICALS%20LTD&page=%2Fdata%2Fform-d%2Fcompany%2Fsalix-pharmaceuticals-ltd-1009356)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 8510 Colonnade Center Drive, Raleigh, NC, 27615
- Phone: (919) 862-1000
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Over $100,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1009356

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 10, 2014 | New notice | $750,000,000 | $750,000,000 | $0 | 7 | Dec 27, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1009356/000120919114002846/0001209191-14-002846-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Thomas W. D'Alonzo | Director |  |
| William P. Forbes | Executive Officer |  |
| John F. Chappell | Director |  |
| Mark A. Sirgo | Director |  |
| William P. Keane | Director |  |
| Carolyn J. Logan | Executive Officer, Director |  |
| Adam C. Derbyshire | Executive Officer |  |
| Rick D. Scruggs | Executive Officer |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Jan 6, 2014](https://specstream.ai/data/form-d/week/2014-01-06) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SALIX PHARMACEUTICALS LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).